Benzinga | Aug 5, 2020 04:39PM EDT

Heron Therapeutics Q2 EPS $(0.61) Up From $(0.63) YoY, Sales $22.67M Down From $36.66M YoY

Heron Therapeutics (NASDAQ:HRTX) reported quarterly losses of $(0.61) per share. This is a 3.17 percent increase over losses of $(0.63) per share from the same period last year. The company reported $22.67 million in sales this quarter. This is a 38.17 percent decrease over sales of $36.66 million the same period last year.